|Articles|December 12, 2019
Almac Group and Exostar Collaborate
Advertisement
Almac Clinical Technologies, a member of the Almac Group, has announced the launch of an integration between its Interactive Response Technology platform-IXRS 3, and Exostar’s Identity and Access Management Platform.
To learn more about the collaboration, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Establishing Governance for No-Code AI in Clinical Operations
3
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
4
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
